A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score

Gleason, 1974, Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging, J Urol, 111, 58, 10.1016/S0022-5347(17)59889-4

Epstein, 2005, ISUP Grading Committee. The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma, Am J Surg Pathol, 29, 1228, 10.1097/01.pas.0000173646.99337.b1

Epstein JI, Egevad L, Amin MB, Delahunt B, Srigley JR, Humphrey PA. The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: definition of grading patterns and proposal for a new grading system. Am J Surg Pathol. In press.

Pierorazio, 2013, Prognostic Gleason grade grouping: data based on the modified Gleason scoring system, BJU Int, 111, 753, 10.1111/j.1464-410X.2012.11611.x

Spratt, 2014, Comparison of high-dose (86.4Gy) IMRT vs combined brachytherapy plus IMRT for intermediate-risk prostate cancer, BJU Int, 114, 360, 10.1111/bju.12514

Videtic, 2014

Resnick, 2013, Long-term functional outcomes after treatment for localized prostate cancer, N Engl J Med, 368, 436, 10.1056/NEJMoa1209978

Wilt, 2012, Radical prostatectomy versus observation for localized prostate cancer, N Engl J Med, 367, 203, 10.1056/NEJMoa1113162

Bill-Axelson, 2014, Radical prostatectomy or watchful waiting in early prostate cancer, N Engl J Med, 370, 932, 10.1056/NEJMoa1311593

D’Amico, 1998, Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer, JAMA, 280, 969, 10.1001/jama.280.11.969

Chan, 2000, Prognostic significance of Gleason score 3+4 versus Gleason score 4+3 tumor at radical prostatectomy, Urology, 56, 823, 10.1016/S0090-4295(00)00753-6

Stark, 2009, Gleason score and lethal prostate cancer: does 3+4=4+3?, J Clin Oncol, 27, 3459, 10.1200/JCO.2008.20.4669

Tsao, 2015, Patients with biopsy Gleason 9 and 10 prostate cancer have significantly worse outcomes compared with Gleason 8 disease, J Urol, 194, 91, 10.1016/j.juro.2015.01.078

Mellinger, 1977, Prognosis of prostatic carcinoma, Recent Results Cancer Res, 60, 61, 10.1007/978-3-642-81095-4_6

Danneman, 2015, Gleason inflation 1998-2011: a registry study of 97 168 men, BJU Int, 115, 248, 10.1111/bju.12671

McNeal, 1996, Spread of adenocarcinoma within prostatic ducts and acini. Morphologic and clinical correlations, Am J Surg Pathol, 20, 802, 10.1097/00000478-199607000-00003

Ross, 2012, Do adenocarcinomas of the prostate with Gleason score (GS) </=6 have the potential to metastasize to lymph nodes?, Am J Surg Pathol, 36, 1346, 10.1097/PAS.0b013e3182556dcd

Kweldam, 2015, Cribriform growth is highly predictive for postoperative metastasis and disease-specific death in Gleason score 7 prostate cancer, Mod Pathol, 28, 457, 10.1038/modpathol.2014.116

Nakabayashi, 2013, Clinical predictors of survival in men with castration-resistant prostate cancer: evidence that Gleason score 6 cancer can evolve to lethal disease, Cancer, 119, 2990, 10.1002/cncr.28102

Esserman, 2014, Addressing overdiagnosis and overtreatment in cancer: a prescription for change, Lancet Oncol, 15, e234, 10.1016/S1470-2045(13)70598-9

Berman, 2014, When is prostate cancer really cancer?, Urol Clin North Am, 41, 339, 10.1016/j.ucl.2014.01.006

Carter, 2012, Gleason score 6 adenocarcinoma: should it be labeled as cancer?, J Clin Oncol, 30, 4294, 10.1200/JCO.2012.44.0586

Nelson, 2014, Observation for clinically localized prostate cancer, J Clin Oncol, 32, 1295, 10.1200/JCO.2013.54.2043

Epstein, 2012, Upgrading and downgrading of prostate cancer from biopsy to radical prostatectomy: incidence and predictive factors using the modified Gleason grading system and factoring in tertiary grades, Eur Urol, 61, 1019, 10.1016/j.eururo.2012.01.050

Brockman, 2015, Nomogram predicting prostate cancer-specific mortality for men with biochemical recurrence after radical prostatectomy, Eur Urol, 67, 1160, 10.1016/j.eururo.2014.09.019

Freedland, 2005, Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy, JAMA, 294, 433, 10.1001/jama.294.4.433

Trock, 2009, Tertiary Gleason patterns and biochemical recurrence after prostatectomy: proposal for a modified Gleason scoring system, J Urol, 182, 1364, 10.1016/j.juro.2009.06.048

Cronin, 2010, Definition of biochemical recurrence after radical prostatectomy does not substantially impact prognostic factor estimates, J Urol, 183, 984, 10.1016/j.juro.2009.11.027

Nielsen, 2008, Is it possible to compare PSA recurrence-free survival after surgery and radiotherapy using revised ASTRO criterion--“nadir + 2”?, Urology, 72, 389, 10.1016/j.urology.2007.10.053

Lee, 2015, Are biochemical recurrence outcomes similar after radical prostatectomy and radiation therapy? Analysis of prostate cancer-specific mortality by nomogram-predicted risks of biochemical recurrence, Eur Urol, 67, 204, 10.1016/j.eururo.2014.09.017